🚀 VC round data is live in beta, check it out!
Atlas Arteria Valuation Multiples
Discover revenue and EBITDA valuation multiples for Atlas Arteria and similar public comparables like Granite Construction, Pinfra, Parkin, Zhejiang Expressway and more.
Atlas Arteria Overview
About Atlas Arteria
Atlas Arteria is a global toll-road investor created out of the reorganization of Macquarie Infrastructure Group in 2010. The firm's main asset is a 30.82% stake in Autoroutes Paris-Rhin-Rhone, or APRR. APRR owns concessions to toll more than 2,300 kilometers of motorways in eastern France, most ending late 2035. The firm also wholly owns the Dulles Greenway and 66.67% of the Chicago Skyway, both in the US.
Founded
2009
HQ
Employees
3.3K
Website
Sectors
Financials (FY)
EV
$6B
Atlas Arteria Financials
Atlas Arteria reported last fiscal year revenue of $114M and EBITDA of $258M.
In the same fiscal year, Atlas Arteria generated $98M in gross profit, $258M in EBITDA, and $187M in net income.
Revenue (LTM)
Atlas Arteria P&L
In the most recent fiscal year, Atlas Arteria reported revenue of $114M and EBITDA of $258M.
Atlas Arteria expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $114M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $98M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 86% | XXX | XXX | XXX |
| EBITDA | — | XXX | $258M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 226% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (11%) | XXX | XXX | XXX |
| Net Profit | — | XXX | $187M | XXX | XXX | XXX |
| Net Margin | — | XXX | 163% | XXX | XXX | XXX |
| Net Debt | — | — | $1B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Atlas Arteria Stock Performance
Atlas Arteria has current market cap of $5B, and enterprise value of $6B.
Market Cap Evolution
Atlas Arteria's stock price is $3.52.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6B | $5B | 0.3% | XXX | XXX | XXX | $0.13 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAtlas Arteria Valuation Multiples
Atlas Arteria trades at 53.9x EV/Revenue multiple, and 23.8x EV/EBITDA.
EV / Revenue (LTM)
Atlas Arteria Financial Valuation Multiples
As of April 29, 2026, Atlas Arteria has market cap of $5B and EV of $6B.
Equity research analysts estimate Atlas Arteria's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Atlas Arteria has a P/E ratio of 27.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV (current) | $6B | XXX | $6B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 53.9x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 23.8x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (509.2x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 62.6x | XXX | XXX | XXX |
| P/E | — | XXX | 27.3x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 21.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Atlas Arteria Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Atlas Arteria Margins & Growth Rates
Atlas Arteria's revenue in the last fiscal year grew by 20%.
Atlas Arteria's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Atlas Arteria's rule of 40 is 40% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Atlas Arteria's rule of X is 70% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Atlas Arteria Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 20% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 226% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (90%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 40% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 70% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 25% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 101% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Atlas Arteria Public Comps
See public comps and valuation multiples for other Road Infrastructure comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Atlas Arteria | XXX | XXX | XXX | XXX | XXX | XXX |
| Granite Construction | XXX | XXX | XXX | XXX | XXX | XXX |
| Pinfra | XXX | XXX | XXX | XXX | XXX | XXX |
| Parkin | XXX | XXX | XXX | XXX | XXX | XXX |
| Zhejiang Expressway | XXX | XXX | XXX | XXX | XXX | XXX |
| Anhui Expressway | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Atlas Arteria M&A Activity
Atlas Arteria acquired XXX companies to date.
Last acquisition by Atlas Arteria was on XXXXXXXX, XXXXX. Atlas Arteria acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Atlas Arteria
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAtlas Arteria Investment Activity
Atlas Arteria invested in XXX companies to date.
Atlas Arteria made its latest investment on XXXXXXXX, XXXXX. Atlas Arteria invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Atlas Arteria
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Atlas Arteria
| When was Atlas Arteria founded? | Atlas Arteria was founded in 2009. |
| Where is Atlas Arteria headquartered? | Atlas Arteria is headquartered in Australia. |
| How many employees does Atlas Arteria have? | As of today, Atlas Arteria has over 3K employees. |
| Who is the CEO of Atlas Arteria? | Atlas Arteria's CEO is Hugh Wehby. |
| Is Atlas Arteria publicly listed? | Yes, Atlas Arteria is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Atlas Arteria? | Atlas Arteria trades under ALX ticker. |
| When did Atlas Arteria go public? | Atlas Arteria went public in 2010. |
| Who are competitors of Atlas Arteria? | Atlas Arteria main competitors are Granite Construction, Pinfra, Parkin, Zhejiang Expressway. |
| What is the current market cap of Atlas Arteria? | Atlas Arteria's current market cap is $5B. |
| What is the current revenue of Atlas Arteria? | Atlas Arteria's last fiscal year revenue is $114M. |
| What is the current revenue growth of Atlas Arteria? | Atlas Arteria revenue growth (vs. last FY) is 20%. |
| What is the current EV/Revenue multiple of Atlas Arteria? | Current revenue multiple of Atlas Arteria is 53.9x. |
| Is Atlas Arteria profitable? | No, Atlas Arteria is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.